Stefanicka Patrik, Krupkova Katarina, Pavlovcinová Gabriela
Department of Otorhinolaryngology-Head and Neck Surgery, Medical Faculty, Comenius University Bratislava, 851 07 Bratislava, Slovakia.
Department of Otorhinolaryngology-Head and Neck Surgery, Bory Hospital, 841 03 Bratislava, Slovakia.
Medicina (Kaunas). 2024 Nov 24;60(12):1932. doi: 10.3390/medicina60121932.
: Despite the distinct entity of both p16-positive and p16-negative squamous cell carcinoma unknown primary in the head and neck (HNSCCUP), the diagnostic workup did not differ. The aim of the study was to determine the effectiveness of palatine tonsillectomy in the identification of primary tumours in two groups of p16-positive and p16-negative HNSCCUP. : Patients with HNSCCUP managed in two tertiary care referral centres from 1 January 2014 to 31 December 2020 were analysed retrospectively. : Sixty-six patients with HNSCCUP diagnosis were included consecutively. HPV status of metastatic cervical lymph nodes using immunohistochemistry with p16 protein was available for all patients. The proportion of both p16-positive and p16-negative groups was not significantly different ( = 0.242). Of the 39 patients who underwent palatine tonsillectomy, tonsillar cancers were revealed histologically in 6 (15.4%) patients, and all these patients were p16-positive. No primary tonsillar tumour was found in the p16-negative group (0 of 17). The primary tumour identification rate in p16-positive HNSCCUP patients using palatine tonsillectomy was 27% (6 of 22). : The diagnostic workup of HNSCCUP should be guided according to HPV/p16 status. Palatine tonsillectomy is a useful procedure in identifying primary cancer in p16-positive SCCUP patients, however, its effectiveness in p16-negative patients is debatable.
尽管头颈部不明原发灶的p16阳性和p16阴性鳞状细胞癌(HNSCCUP)是不同的实体,但诊断检查并无差异。本研究的目的是确定腭扁桃体切除术在两组p16阳性和p16阴性HNSCCUP中识别原发肿瘤的有效性。:回顾性分析了2014年1月1日至2020年12月31日在两个三级医疗转诊中心接受治疗的HNSCCUP患者。:连续纳入66例诊断为HNSCCUP的患者。所有患者均通过p16蛋白免疫组化获得转移性颈部淋巴结的HPV状态。p16阳性和p16阴性组的比例无显著差异(=0.242)。在39例行腭扁桃体切除术的患者中,6例(15.4%)组织学检查发现扁桃体癌,所有这些患者均为p16阳性。p16阴性组未发现原发性扁桃体肿瘤(17例中0例)。使用腭扁桃体切除术在p16阳性HNSCCUP患者中的原发肿瘤识别率为27%(22例中6例)。:HNSCCUP的诊断检查应根据HPV/p16状态进行指导。腭扁桃体切除术在识别p16阳性SCCUP患者的原发性癌症方面是一种有用的方法,然而,其在p16阴性患者中的有效性存在争议。